Prosecution Insights
Last updated: November 20, 2026

Catalent U K Swindon Zydis Limited

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Catalent U K Swindon Zydis Limited has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This workload is assigned to 1 distinct examiner and 1 distinct art unit. The presence of only 1 pending matter indicates a specific or limited engagement with the patent office at this time. Practitioners should focus on the unique requirements of this art unit to ensure the application progresses efficiently through the examination phase.

The busiest examiner for this portfolio is KASSA, TIGABU, who is currently handling 1 pending office action. This single action constitutes the full extent of the company's pending prosecution before the USPTO. Because the busiest examiner pending count is 1 and the total pending office actions is 1, the company's immediate patent outcomes are tied to this specific examiner's review. Practitioners should tailor their approach to the specific standards of the Biotechnology & Pharmaceuticals area as applied by KASSA, TIGABU. Navigating the preferences of this 1 distinct examiner is essential for successful prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KASSA, TIGABU 1 36.6% +27.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18030541 STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE KASSA, TIGABU 44d overdue

Top Art Units

Art UnitApps
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18030541 STABLE ORAL DISPERSIBLE FORMULATION FOR EPINEPHRINE KASSA, TIGABU 1619 §103 Non-Final OA 44d overdue Pending Apr 06, 2023

Managing Catalent U K Swindon Zydis Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Catalent U K Swindon Zydis Limited have?

Catalent U K Swindon Zydis Limited has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Catalent U K Swindon Zydis Limited applications?

Tigabu Kassa has the most, with 1 of Catalent U K Swindon Zydis Limited's pending office actions.

What technology area are Catalent U K Swindon Zydis Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month